The markets closed mixed with the Dow plunging 141 points to 17,672 over disappointing home sales data. Nasdaq added 7 points to 4,757.
On the upside
The Food and Drug Administration approved Nevro's (NYSE: NVRO) Senza spinal cord stimulation system.
Bargain hunters lifted shares of Eagle Pharmaceuticals (Nasdaq: EGRX).
Otonomy (Nasdaq: OTIC) priced its follow-on pubic offering of 2.55 million common shares at $29.25 per share.
On the downside
Goldman Sachs cut its 2015 iron ore forecast sending shares of Cliffs Natural Resources (NYSE: CLF) tumbling.
Shares of Alpha Natural Resources (NYSE: ANR) fell after Standard & Poor's said that coal prices would remain depressed this year.
Shares of Alamos Gold (NYSE: AGI) extended its losses.
In the broad market, declining issues outpaced advancers by a margin of 5 to 4 on the NYSE and on Nasdaq. The broader S&P 500 dropped 11 points to 2051. Bitcoin added $3 to $232.
Mixed close over home sales data
January 23, 2015 at 17:40 PM EST